Valiant Laboratories Limited Share Price & Stock Analysis

Valiant Laboratories Limited operates as an active pharmaceutical ingredient/bulk drug manufacturing company in India and internationally. The company manufactures paracetamol in various grades, such as Indian/British/European/the United States pharmacopoeias for the treatment of headaches, muscle aches, arthritis, back aches, toothaches, cold, and fever. It also offers specialty chemicals. The company was formerly known as Bharat Chemicals and changed its name to Valiant Laboratories Limited in August 2021. The company was founded in 1980 and is based in Mumbai, India. Valiant Laboratories Limited is a subsidiary of Dhanvallabh Ventures LLP.

Key Metrics

Current Price₹62.22
Market Cap₹0 Cr
SectorHealth Care > Pharmaceuticals, Biotechnology and Life Sciences > Pharmaceuticals
Sub-IndustryPharmaceuticals > Health Care; Pharmaceuticals, Biotechnology and Life Sciences; Pharmaceuticals; Pharmaceuticals; Pharmaceutical Products
P/E Ratio-122
52-Week Range₹49.51 – ₹115.05

Business Segments

1. Manufacturing of Chemicals Business-100%

Peer Companies

Frequently Asked Questions

What is the current share price of Valiant Laboratories Limited?

Valiant Laboratories Limited is trading at ₹62.22, with a market capitalisation of ₹0 Cr.

Which sector does Valiant Laboratories Limited belong to?

Valiant Laboratories Limited operates in the Health Care > Pharmaceuticals, Biotechnology and Life Sciences > Pharmaceuticals space (Pharmaceuticals > Health Care; Pharmaceuticals, Biotechnology and Life Sciences; Pharmaceuticals; Pharmaceuticals; Pharmaceutical Products).

What are the key financial ratios of Valiant Laboratories Limited?

Valiant Laboratories Limited has a P/E of -122.